Xionggao Huang

Dr. Xionggao Huang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
YHYikeng Huang
Yikeng Huang
WHWeiwen Hu
Weiwen Hu
XHXionggao Huang
Xionggao Huang
Background: Retinal hemangioblastoma (RH) is a rare benign tumor and a considerable number of which are caused by Von Hippel-Lindau disease (VHL). Herein, we described a case of VHL-associated RH with retinal detachment who underwent both laser photocoagulation and vitreoretinal surgery and received satisfactory visual recovery. In addition, we reviewed the current diagnosis, genotype-phenotype association, and treatment of VHL-associated RH.Case description: A 34-year-old woman presented with vision loss in the right eye at our hospital. Fundus photography and angiography showed retinal detachment and multiple large hemangiomas in the right eye. The visual acuity improved significantly after laser photocoagulation and vitreoretinal surgery. Genetic analyses showed a p.Asn78Ser (c.233A>G) heterozygous missense mutation in the VHL gene.Conclusion: We described a rare case of VHL-associated RH and may provide a new perspective towards diagnosis and treatment of this disease. RH is one of the most common manifestations of VHL and poses a serious threat to vision. Ophthalmic examination methods include fundus examination and fundus photography, etc. The management of the disease emphasizes timely follow-up, early detection of the lesion, and the decision of treatment options according to the size, location and complications of the lesion, including ablation therapy and vitreoretinal surgery. Clinicians should strengthen the understanding of this rare disease for early detection and treatment.

1 October 2020 in Experimental and Molecular Pathology
Verified
Journal Article
Closed access
LWLing Wang
Ling Wang
WLWei-Xian Liu
Wei-Xian Liu
XHXionggao Huang
Xionggao Huang

28 February 2024 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
YFYanyun Fan
Yanyun Fan
YHYikeng Huang
Yikeng Huang
XHXionggao Huang
Xionggao Huang
Purpose. To analyze the distribution characteristics of axial length to corneal curvature radius ratio (AL/CR) and other ocular biometric parameters in adult myopia patients and their association with myopia. Methods. A cross-sectional study was conducted among patients with no eye diseases except ametropia who attended the optometry clinic of the First Affiliated Hospital of Hainan Medical College from January 2022 to June 2022. In total, 187 eyes (right eye) of 187 myopic patients aged 18–35 years were selected by random sampling. Based on the results of spherical equivalent (SE, (D)) obtained by postdilation optometry, all subjects were divided into three groups: mild myopia (≤−0.50D and >−3.00D, 42 eyes), moderate myopia (≤−3.00D and >−6.00D, 80 eyes), and high myopia (≤−6.00D, 65 eyes). The axial length (AL), corneal curvature radius (CR), and AL/CR were measured and compared between the three groups. The association between AL and AL/CR of the eye and SE was analyzed by multiple linear regression. Also, the predictive ability of AL/CR for high myopia was investigated by ROC curve. Results. There were no statistically significant differences in age, gender, or intraocular pressure between the three groups. The mean values of AL/CR in mild, moderate, and high myopia groups were 3.17 ± 0.06, 3.31 ± 0.08, and 3.43 ± 0.10, respectively, and the difference between the groups was statistically significant ). Linear regression analysis showed that both AL and AL/CR were strongly negatively correlated with SE ( ), while CR had a weak positive correlation with SE without statistically significant differences ( ). The adjusted linear regression equation shows that for every 0.1 unit increase in AL/CR, SE increases by 1.54 D. Compared with 0.830 (95% confidence interval: 0.769 to 0.900) for AL, the area under ROC curve of AL/CR was 0.896 (95% confidence interval: 0.851 to 0.941), indicating that the diagnostic value of AL/CR for high myopia was higher than that of AL ( ). When the Youden index reached its maximum (0.626), the AL/CR cutoff point was 3.309, and the sensitivity and specificity were 0.954 and 0.672, respectively. Conclusion. This study showed that AL and AL/CR in adult myopia patients were significantly negatively correlated with SE, and the corralation between AL/CR and SE is greater than that between AL and SE. Therefore, AL/CR can be used to analyze the dynamic changes of SE in the development of adult myopia independently of optometry on a certain basis, and it is especially suitable for the diagnosis of high myopia in adults. This trial is registered with ChiCTR2300069070.

20 May 2025 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
HLHuan Shen Li
Huan Shen Li
XHXionggao Huang
Xionggao Huang
Fundus neovascularization disease is a blinding eye disease, and represents an umbrella term for a group of disorders in which VEGF and its receptor VEGFR2 play important roles in promoting neovascularization. Compared with physiological angiogenesis, pathological angiogenesis involves several different regulatory mechanisms, vascular structures and functions, as well as microenvironmental effects. Although the role of VEGF and its receptor in angiogenesis is well documented, research on its major molecular signaling mechanisms is limited. In the present review, a basic overview of the VEGF and VEGFR2 pathways, including their downstream signaling mechanisms and the latest therapeutic advances in the context of fundus neovascularization disease, is provided, and the limitations and future perspectives of current anti‑VEGF therapies are discussed. Overall, the purpose of the current review is to provide information on the molecular signaling mechanisms associated with VEGF and VEGFR2 and to perform an in‑depth examination of these molecular signaling pathways and their interaction mechanisms. These interaction mechanisms are expected to facilitate the development of more targeted and long‑lasting therapeutic regimens and provide novel concepts for the treatment of fundus neovascularization disease.

21 March 2025 in Medicine
Verified
Journal Article
Open access
GYGukun Yang
Gukun Yang
XHXionggao Huang
Xionggao Huang
Long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and retinopathy are 2 distinct yet interconnected areas of research in the field of ocular studies. MALAT1, with its diverse biological functions, has been extensively studied and demonstrated to play a role in various diseases, including ocular pathologies. Its involvement in alternative splicing regulation, transcriptional control, and the competing endogenous RNA (ceRNA) network suggests its potential implication in retinopathy. Retinopathy refers to a group of disorders that affect the retina, leading to vision impairment and, in severe cases, even blindness. These conditions include diabetic retinopathy, retinoblastoma, proliferative vitreoretinopathy, retinopathy of prematurity, and retinal neurodegeneration. The understanding of the molecular mechanisms underlying the development and progression of retinopathy, along with the potential involvement of MALAT1, can provide valuable insights for the diagnosis and treatment of this condition. Retinopathy, characterized by various manifestations and underlying mechanisms, presents a significant challenge in the field of ophthalmology. As a complex disease, its pathogenesis involves multifactorial factors, including angiogenic dysregulation, inflammatory responses, oxidative stress, and cellular signaling abnormalities. The emerging role of long noncoding RNA MALAT1 in retinopathy has attracted considerable attention. MALAT1 has been found to participate in multiple cellular processes, including alternative splicing regulation and transcriptional control. Additionally, the competing endogenous RNA (ceRNA) network involving MALAT1 indicates its potential relevance as a regulator in retinopathy. Further investigations into the specific mechanisms underlying MALAT1’s involvement in retinopathy pathogenesis may provide valuable insights into the development of diagnostic and therapeutic approaches for managing retinal disorders.

19 May 2022 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
WHWei-Wen Hu
Wei-Wen Hu
YHYi-Keng Huang
Yi-Keng Huang
XHXionggao Huang
Xionggao Huang
To compare the differences in peripheral blood inflammatory indices between patients with neovascular age-related macular degeneration (nAMD) and haemorrhagic polypoidal choroidal vasculopathy (PCV...